Partner Therapeutics, Inc.
General Information
Identification Code: 804680091504-89
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 3/30/2024
EP Accredited Number: 0
Mission & Interests
Goals: Partner Therapeutics is developing treatments to address unmet medical needs with a focus on hematology/oncology indications and health security/critical care. Our global focus for Health Security and Critical Care is to develop therapies that have dual use and broad spectrum potential, and includes therapies to address sepsis and acute radiation distress syndrome, autoimmune pulmonary proteinosis, and trauma that have "dual use" as treatments against chemical, biological and radiological/nuclear threats.
The Company has discussed a Marketing Authorization Application (MAA) submission for its radiation exposure treatment with the European Commission Emergency Task Force and the European Medicines Agency (EMA) and was recently granted Accelerated Assessment of this submission. The MAA will be submitted to EMA no later than April 6, 2024.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Public health
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Regulation (EU) 2022/2371 - The Union Prevention Preparedness and Response Plan
Commission Decision C(2014) 2258 - Joint Procurement Agreement to procure medical countermeasures pursuant to Decision 1082/2013/EU
Funding for preparedness and stockpiling of medical countermeasures for chemical, biological, radiological and nuclear threats
Communication Activities: - Written, virtual and in-person communications and submissions to the European Medicines Agency in support of potential approval for medical countermeasures to treat chemical, biological, radiological and nuclear threats.
- Written communications and virtual and in-person meetings with HERA, ECHO and rescEU regarding the need for adequate preparedness and response, potential solutions for challenges and solutions for preparedness and response to chemical, biological, radiological and nuclear threats.
- Potential outreach and communication with other interested parties regarding preparedness and response.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 19 Muzzey Street, Suite 105
Post Code: 02421
City: Lexington
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 19 Muzzey Street, Suite 105
Post Code: 02421
City: Lexington
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 2
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 0.20000000298023224
Info Members: The Company has opened an office in Ireland and plans to increase its activities in the European Union if its product(s) are approved by EMA for use in patients and/or for use in the event of a chemical, biological, radiological or nuclear incident.
Structure
Structure Type: Structure
Organisation Members: Radiation Research Society - https://www.radres.org/
Society of Critical Care Medicine - https://www.sccm.org/Home